Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger L Sur

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
The Journal of Urology|August 1, 2023
A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report From the EDGE Consortium. ReplyRoger L Sur
The Journal of Urology|January 24, 2012
Editorial commentRoger L Sur
Journal of Endourology|February 24, 2015
Editorial comment for Tosoian et alRoger L Sur
European Urology|October 16, 2024
Re: Frédéric Panthier, Vineet Gauhar, Eugenio Ventimiglia, Jia-Lun Kwok, Etienne Xavier, Olivier Traxer. Rethinking Stone-free Rates and Surgical Outcomes in Endourology: A Point of View from PEARLS Members. Eur Urol. 2024;86:198-199Roger L Sur
The Journal of Urology|December 26, 2017
Editorial CommentRoger L Sur
Journal of Endourology|October 1, 2014
Editorial comment for Abbott et alRoger L Sur
BJU International|June 13, 2012
Editorial comment: Primary prevention of nephrolithiasis is cost-effective for a national healthcare systemRoger L Sur
The Journal of Urology|June 16, 2021
Editorial CommentRoger L Sur
BJU International|April 11, 2014
How are we doing with percutaneous nephrolithotomy (PCNL) in England?Roger L Sur
BJU International|March 17, 2010
Evidence-based urology in practice: Kaplan-Meier analysisRoger L Sur, Philipp Dahm,
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
The Journal of Urology|August 1, 2023
A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report From the EDGE Consortium. ReplyRoger L Sur
The Journal of Urology|January 24, 2012
Editorial commentRoger L Sur
Journal of Endourology|February 24, 2015
Editorial comment for Tosoian et alRoger L Sur
European Urology|October 16, 2024
Re: Frédéric Panthier, Vineet Gauhar, Eugenio Ventimiglia, Jia-Lun Kwok, Etienne Xavier, Olivier Traxer. Rethinking Stone-free Rates and Surgical Outcomes in Endourology: A Point of View from PEARLS Members. Eur Urol. 2024;86:198-199Roger L Sur
The Journal of Urology|December 26, 2017
Editorial CommentRoger L Sur
Journal of Endourology|October 1, 2014
Editorial comment for Abbott et alRoger L Sur
BJU International|June 13, 2012
Editorial comment: Primary prevention of nephrolithiasis is cost-effective for a national healthcare systemRoger L Sur
The Journal of Urology|June 16, 2021
Editorial CommentRoger L Sur
BJU International|April 11, 2014
How are we doing with percutaneous nephrolithotomy (PCNL) in England?Roger L Sur
BJU International|March 17, 2010
Evidence-based urology in practice: Kaplan-Meier analysisRoger L Sur, Philipp Dahm,
Pageof 13